ABILIFY Maintena 400 mg subst seche 400mg pce
7680631770041
CH-63177
N05AX12
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Abilify Maintena 400 mg, Depot-Injektionssuspension
Injektionssuspension
400 mg
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
aripiprazolum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
aripiprazolum monohydricum
|
- | Substance | WIZUS |
|
carmellosum natricum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Authorization holder
Lundbeck (Schweiz) AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 63177
- Drug name
- Abilify Maintena, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
- Galenic form
- PULMS
- ATC Code
- N05AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/04/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABILIFY Maintena 400 mg subst seche 400mg pce
- Description (DE)
- ABILIFY Maintena 400 mg Trockensub 400mg Stk
- Market launch
- 15/03/2016
- Narcotic (BTM)
- No